United Nations Environment Programme
   Ozone Secretariat
Search
Handbook for the Montreal Protocol on Substances
that Deplete the Ozone Layer - 7th Edition (2006)

Advanced search
Sections   Section One The Montreal
Protocol 		Section Two Decisions Section Three Annexes Section Four Rules of
Procedure 		Section Five Sources of Further
Information 		General Index General
Index
PreviousPrevious Next Next

Decision IX/18: Essential-use nominations for non-Article 5 Parties for controlled substances for 1998 and 1999

The Ninth Meeting of the Parties decided in Dec. IX/18:

  1. To note with appreciation the excellent work done by the Technology and Economic Assessment Panel and its Technical Options Committees;
  2. That the levels of production and consumption necessary to satisfy essential uses of CFC-11, CFC-12, CFC-113 and CFC-114, for metered-dose inhalers (MDIs) for asthma and chronic obstructive pulmonary diseases, and halon 2402 for fire protection are authorized as specified in annex VI to the report of the Ninth Meeting of the Parties [see Section 3.2 of this Handbook], subject to the conditions established by the Meeting of the Parties in paragraph 2 of its decision VII/28;
  3. To approve the authorization by the Secretariat of the emergency use of 3 tonnes for 1997 for CFC-12 for sterile aerosol talc submitted as an essential-use nomination by United States of America.

 

PreviousPrevious Next Next
Sections   Section One The Montreal
Protocol 		Section Two Decisions Section Three Annexes Section Four Rules of
Procedure 		Section Five Sources of Further
Information 		General Index General
Index
Front Cover Foreword Introduction Contents Back Cover

 
  © Ozone Secretariat 2004